Вы находитесь на странице: 1из 13

New nebulized therapy for the management of chronic pulmonary infection due to P aeruginosa in cystic fibrosis patients 6+

Keep them safe and secure from the threat of pseudomonas.

NEW

Comfort you can count on

tobramycin 300mg/4mL nebulizer solution

BRAMITOB

New nebulized therapy for the management of chronic pulmonary infection due to P aeruginosa in cystic fibrosis patients 6+

The confidence of knowing

theyre facing the world fully protected

NEW

tobramycin 300mg/4mL nebulizer solution


Secure their childhood

BRAMITOB

New nebulized therapy for the management of pulmonary infection due to P aeruginosa in cystic fibrosis patients 6+

security
like this should be a part of their lives
NEW

tobramycin 300mg/4mL nebulizer solution


Youll all breathe easier

BRAMITOB

NEW

tobramycin 300mg/4mL nebulizer solution

BRAMITOB
NEW

tobramycin 300mg/4mL nebulizer solution

BRAMITOB

vivid purple

golden yellow

warm red

Blends the excitement of red with the tranquility and trust of blue. It has a futuristic quality that speaks to cutting-edge products.

A warm, nurturing color seen as both optimistic and approachable. It emanates a sense of eye-catching energy and enlightenment.

Combines the exciting, dynamic and confident personality of red with the friendly and childlike intensity of orange.

BLANKET PROTECTION PROGRAM

95%

of parents say they feel secure that their children are receiving the full dose of therapy with nebulized Bramitob.
Learn more to see if it's right for your patients.

F o r r a i s i n g N a + l e v e l s i n p a t i e n t s w i t h e u v o l e m i c h y p o n a t r e m i a a s s o c i a t e d w i t h S I A D H

M a k e t h e c l i m b a t a p a c e t h a t s p r o t e c t i v e
s l o wa n ds t e a d y k e e p s t h e ms a f e

F o r e u v o l e m i c h y p o n a t r e m i a a s s o c i a t e d w i t h S I A D H

S l o wa n ds t e a d yw i n st h er a c e a g a i n s t h y p o n a t r e mi a

e a s y d o e s i t

For euvolemic hyponatremia associated with SIADH

The slower the ascent, the safer the arrival

Normalize Na+ levels graduallyto safely treat hyponatremia in the outpatient setting

Lixivaptan
ITS ABOUT TIME

New

For euvolemic hyponatremia associated with SIADH

Finally, the treatment of hyponatremia hits home.

Slow, steady Na+ normalizationto safely treat hyponatremia in the outpatient setting.

Na+ levels (mmol/L) 0

4 Days

Lixivaptan
OUT IS THE NEW IN

New

teal blue

bright violet

cool gray

Blends the dependability of blue with the soothing, healing nature of green to create a color thats both reassuring and serene.

Unites game-changing creativity and spirituality with a sense of regal elegance and sophistication.

Provides a sense of timelessness, neutrality and inclusiveness that complements and supports virtually every palette.

Lixivaptan
Lixivaptan
New

New

Вам также может понравиться